Coagulation enzymes are trypsin-like serine proteases with a PI specificity of Arg, but unlike trypsin, they exhibit high degrees of primary substrate specificity, require complex formation with a cofactor to function and are inhibited by a small subset of protease inhibitors. Although the three dimensional structure of these enzymes are highly conserved, certain residues on the surface, particularly those found in the extended binding pockets vary among coagulation proteases. We hypothesize that the variable residues, at least in part, determine the differences in primary substrate specificity in coagulation enzymes. We will test this hypothesis by mutagenesis of the variant residues in protein C, factor X and prothrombin. The experimental strategy we will use is to identify the variant residue(s) by homology modeling, replace these residue(s) with those found in the analogous site of a different family member and determine if the specificity is switched toward that of the donor enzyme. We further hypothesize that cofactors may influence the substrate specificity by altering the conformation of these-variant residue(s) by allosteric mechanisms and eliminating potentially inhibitory interactions with substrates. This hypothesis will be tested using both wild type or mutant enzymes containing specific-mutations at the S3-S3' sites and wild type or mutant substrates containing complementary mutations at the P3-P3' sites. The rate of activation of wild type substrates by mutant enzymes or mutant substrates by wild type enzymes in the presence and absence of cofactors will be compared. If the hypothesis is correct, then the mutagenesis should at least partially eliminate the cofactor requirement for zymogen activation. The results will be extended by analysis of inhibition profiles using mutants of bovine pancreatic trypsin inhibitor (BPTI) in which the P3-P3' residues of the inhibitor are substituted with those of the wild type or mutant substrates. In this case a lower Ki with or.without a cofactor present will support the hypothesis. The study will expand our knowledge of the molecular basis of coagulation factor specificity and the mechanism of cofactor function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL054804-02
Application #
5214339
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
van Sluis, G L; Bruggemann, L W; Esmon, C T et al. (2011) Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation. Cancer Lett 306:106-10
Srivastava, Arvind; Wang, Jianfang; Majumder, Rinku et al. (2002) Localization of phosphatidylserine binding sites to structural domains of factor Xa. J Biol Chem 277:1855-63
Alberio, L; Lammle, B; Esmon, C T (2001) Protein C replacement in severe meningococcemia: rationale and clinical experience. Clin Infect Dis 32:1338-46
Liaw, P C; Mather, T; Oganesyan, N et al. (2001) Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor. J Biol Chem 276:8364-70
Faust, S N; Levin, M; Harrison, O B et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408-16
Xu, J; Qu, D; Esmon, N L et al. (2000) Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 275:6038-44
Gu, J M; Katsuura, Y; Ferrell, G L et al. (2000) Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood 95:1687-93
Rezaie, A R; He, X (2000) Sodium binding site of factor Xa: role of sodium in the prothrombinase complex. Biochemistry 39:1817-25
Esmon, C T (2000) The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. J Autoimmun 15:113-6
Taylor Jr, F B; Stearns-Kurosawa, D J; Kurosawa, S et al. (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680-6

Showing the most recent 10 out of 47 publications